<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Puma Biotechnology, Inc. (PBYI) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/pbyi/</link>
<description>Every dated entry in the public record on Puma Biotechnology, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/pbyi/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Fri, 30 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Puma Biotechnology, Inc.: short interest 4,540,314 shares at the 15 October 2026 settlement, 12.88 days to cover</title><link>https://greeksoup.ai/stocks/us/pbyi/short-interest/</link><guid isPermaLink="false">us:PBYI:short-interest:2026-10-15:b7734e2b3a</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: Schedule 13D/A filed by Alan H. Auerbach, 16.0% of the class</title><link>https://greeksoup.ai/stocks/us/pbyi/holders/</link><guid isPermaLink="false">us:PBYI:schedule-13:2026-10-06:c1db2f9e81</guid><pubDate>Tue, 06 Oct 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p class="q">The information set forth or incorporated in Item 3 above is incorporated herein by reference. From time to time, Mr. Auerbach may acquire beneficial ownership of additional shares of Common Stock or other securities of the Issuer by purchase, as compensation from the Issuer, or otherwise, including, but not limited to, awards of restricted Common Shares, options to purchase Common Shares, and restricted stock units for Common Shares, or dispose of some or all of the shares of Common Stock beneficially owned by Mr. Auerbach in the open market or in privately negotiated transactions (which may</p><p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000110465926114167/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: short interest 4,264,923 shares at the 30 September 2026 settlement, 14.02 days to cover</title><link>https://greeksoup.ai/stocks/us/pbyi/short-interest/</link><guid isPermaLink="false">us:PBYI:short-interest:2026-09-30:0e24fd17de</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: Wilson Troy Edward (Director) sold 5,000 shares (under a trading plan set in advance) at $9.10 on 14 September 2026, $45,500</title><link>https://greeksoup.ai/stocks/us/pbyi/insiders/</link><guid isPermaLink="false">us:PBYI:insider:2026-09-16:dca479e67e</guid><pubDate>Wed, 16 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000143774926030597/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: Cesano Alessandra (Director) sold 62,150 shares (under a trading plan set in advance) at $9.12 on 14 September 2026, $566,994</title><link>https://greeksoup.ai/stocks/us/pbyi/insiders/</link><guid isPermaLink="false">us:PBYI:insider:2026-09-16:dae7ed7df0</guid><pubDate>Wed, 16 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000143774926030593/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: short interest 4,319,663 shares at the 15 September 2026 settlement, 13.80 days to cover</title><link>https://greeksoup.ai/stocks/us/pbyi/short-interest/</link><guid isPermaLink="false">us:PBYI:short-interest:2026-09-15:73e740d627</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: Form 144, WILSON TROY EDWARD plans to sell 5,000 shares worth $45,500 around 14 September 2026</title><link>https://greeksoup.ai/stocks/us/pbyi/planned-sales/</link><guid isPermaLink="false">us:PBYI:planned-sale:2026-09-14:7c7bfbce39</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000195917326006917/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: Form 144, Cesano Alessandra plans to sell 62,150 shares worth $565,565 around 14 September 2026</title><link>https://greeksoup.ai/stocks/us/pbyi/planned-sales/</link><guid isPermaLink="false">us:PBYI:planned-sale:2026-09-14:ccb67027f4</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000195917326006918/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: short interest 4,274,524 shares at the 31 August 2026 settlement, 15.62 days to cover</title><link>https://greeksoup.ai/stocks/us/pbyi/short-interest/</link><guid isPermaLink="false">us:PBYI:short-interest:2026-08-31:2a56a44f75</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc.: short interest 4,167,830 shares at the 14 August 2026 settlement, 11.39 days to cover</title><link>https://greeksoup.ai/stocks/us/pbyi/short-interest/</link><guid isPermaLink="false">us:PBYI:short-interest:2026-08-14:a457e3c9de</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc. Q2 FY2026 results: revenue $57 million, net income $8 million</title><link>https://greeksoup.ai/stocks/us/pbyi/results/fy2026-q2/</link><guid isPermaLink="false">us:PBYI:result:2026-08-06:898608a712</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001401667&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc. filed 10-Q: form 10-q</title><link>https://greeksoup.ai/stocks/us/pbyi/filings/</link><guid isPermaLink="false">us:PBYI:filing:2026-08-06:4cc1e07b9d</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000143774926026311/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Puma Biotechnology, Inc. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/pbyi/filings/</link><guid isPermaLink="false">us:PBYI:filing:2026-08-06:dc6e14bac6</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1401667/000143774926026282/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/pbyi/filings/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
